CGB Stock Overview
Cann Global Limited engages in the production and distribution of medicinal cannabis medications, natural foods, and cosmeceuticals in Australia and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Cann Global Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.021 |
| 52 Week High | AU$0.075 |
| 52 Week Low | AU$0.017 |
| Beta | 1.03 |
| 11 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -72.00% |
| 33 Year Change | -94.00% |
| 5 Year Change | -98.38% |
| Change since IPO | -99.60% |
Recent News & Updates
Shareholder Returns
| CGB | AU Pharmaceuticals | AU Market | |
|---|---|---|---|
| 7D | 0% | -10.0% | 0.4% |
| 1Y | -72.0% | 46.9% | 16.9% |
Return vs Industry: CGB underperformed the Australian Pharmaceuticals industry which returned 61.8% over the past year.
Return vs Market: CGB underperformed the Australian Market which returned 9.6% over the past year.
Price Volatility
| CGB volatility | |
|---|---|
| CGB Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 12.0% |
| Market Average Movement | 8.6% |
| 10% most volatile stocks in AU Market | 17.4% |
| 10% least volatile stocks in AU Market | 3.4% |
Stable Share Price: CGB has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine CGB's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | n/a | Sholom Feldman | www.canngloballimited.com |
Cann Global Limited engages in the production and distribution of medicinal cannabis medications, natural foods, and cosmeceuticals in Australia and internationally. It operates through Hemp and Medical Cannabis Products, and Mining Exploration and Evaluation segments. The company grows and cultivates hemp and medical cannabis products; provides nutritious and vitamin packed plant-based foods under the Grass Roots brand; and offers skincare products under the Fuss Pot brand.
Cann Global Limited Fundamentals Summary
| CGB fundamental statistics | |
|---|---|
| Market cap | AU$5.44m |
| Earnings (TTM) | -AU$8.22m |
| Revenue (TTM) | AU$562.34k |
9.7x
P/S Ratio-0.7x
P/E RatioIs CGB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CGB income statement (TTM) | |
|---|---|
| Revenue | AU$562.34k |
| Cost of Revenue | AU$640.53k |
| Gross Profit | -AU$78.20k |
| Other Expenses | AU$8.14m |
| Earnings | -AU$8.22m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.032 |
| Gross Margin | -13.91% |
| Net Profit Margin | -1,461.39% |
| Debt/Equity Ratio | 0% |
How did CGB perform over the long term?
See historical performance and comparison